國家衛生研究院 NHRI:Item 3990099045/7153
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 12145/12927 (94%)
造访人次 : 913690      在线人数 : 1189
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧：
  • 您可在西文检索词汇前后加上"双引号"，以获取较精准的检索结果
  • 若欲以作者姓名搜寻，建议至进阶搜寻限定作者字段，可获得较完整数据
    •  进阶搜寻
    主页 ‧ 登入 ‧ 上传 ‧ 说明 ‧ 关于NHRI ‧ 管理 到手机版


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7153


    题名: TOP2A overexpression as a poor prognostic factor in patients with nasopharyngeal carcinoma
    作者: Lan, J;Li, CF;Chen, TJ;Tai, HC;Huang, HY
    贡献者: National Institute of Cancer Research
    摘要: Background: Despite the advances in diagnostic imaging and treatment modalities, the risk stratification and final outcomes in patients with nasopharyngeal carcinomas (NPC) still remain suboptimal. Through data mining from published transcriptomic database, TOP2A was first identified as a differentially upregulated gene in NPC tissues, which encodes topoisomerase 2 alpha implicating cell division via selective cleavage, rearrangement, and re-ligation of DNA strands. Given the roles of TOP2A in prognostication and as the frontline therapeutic target in common carcinomas, such as breast cancer, we explored the significance of TOP2A immunoexpression status in a well-defined cohort of NPC patients. Design: TOP2A immunohistochemistry was retrospectively performed and analyzed using H-score method for biopsy specimens from 124 NPC patients who received standard treatment without distant metastasis at initial diagnosis. Those cases with H-score larger than the median value were construed as featuring TOP2A overexpression. The results were correlated with the clinicopathological variables, disease-specific survival (DSS), and distant metastasis-free survival (DMFS). Results: TOP2A overexpression was significantly associated with AJCC stages III-IV (p=0.019) and univariately predictive of adverse outcomes for DSS (p=0.0078) and DMFS (p=0.0003). In multivariate comparisons, TOP2A overexpression still remained prognostically independent to portend worse DSS (p=0.047, hazard ratio=1.732) and DMFS (p=0.003, hazard ratio=2.569), together with advanced AJCC stages III-IV. Conclusions: TOP2A expression is upregulated in a subset of NPCs and its increased immunoexpression significantly correlated with advanced stages and tumor aggressiveness, justifying the potentiality of TOP2A as a prognostic biomarker and a novel therapeutic target of NPC.
    日期: 2013-02
    關聯: Laboratory Investigation. 2013 Feb;93(Suppl. 1):308A.
    Link to: http://dx.doi.org/10.1038/labinvest.2013.23
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0023-6837&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000314789301613
    显示于类别:[其他] 會議論文/會議摘要

    文件中的档案:

    档案 描述 大小格式浏览次数
    ISI000314789301613.pdf12032KbAdobe PDF419检视/开启


    在NHRI中所有的数据项都受到原著作权保护.

    TAIR相关文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈